TEST BANK-
Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition by
Linda E. McCuistion, Kathleen Vuljoin DiMaggio, Mary B. Winton, Jennifer J. Yeager
12TH EDITION
, TABLE OF CONTENTS
Unit i: introduction to pharmacology ...................................................................................................... 4
Chapter 01: clinical judgment management model (cjmm) and the nursing process Explanation of
terms ......................................................................................................................................................... 4
Chapter 02: drug development and ethical considerations ................................................................... 27
Chapter 03: pharmacokinetics and pharmacodynamics ........................................................................ 38
Chapter 04: pharmacogenetics ............................................................................................................... 58
Chapter 05: complementary and alternative therapies ......................................................................... 63
Chapter 06: pediatric considerations...................................................................................................... 70
Chapter 07: drug therapy in older adults................................................................................................ 79
Chapter 08: drugs in substance use disorder ......................................................................................... 98
Unit ii: pharmacotherapy and drug administration ................................................................................ 105
Chapter 09: safety and quality .............................................................................................................. 105
Chapter 10: drug administration .......................................................................................................... 114
Chapter 11: drug labels and dosage calculations ................................................................................. 121
Unit iii: maintenance of homeostasis ...................................................................................................... 136
Chapter 12: fluid volume and electrolytes ........................................................................................... 136
Chapter 13: vitamin and mineral replacement ..................................................................................... 148
Chapter 14: nutritional support ............................................................................................................ 158
Unit iv: autonomic nervous system drugs ............................................................................................... 169
Chapter 15: adrenergic agonists and antagonists ................................................................................ 169
Chapter 16: cholinergic agonists and antagonists ................................................................................ 177
Unit v: central and peripheral nervous system drugs ............................................................................. 186
Chapter 17: stimulants .......................................................................................................................... 186
Chapter 18: depressants ....................................................................................................................... 192
Chapter 19: antiseizure drugs ............................................................................................................... 200
Chapter 20: drugs for parkinson disease and alzheimer disease ......................................................... 210
Chapter 21: drugs for neuromuscular disorders and muscle spasms................................................... 219
Unit vi: mental and behavioral health drugs........................................................................................... 228
Chapter 22: antipsychotics and anxiolytics........................................................................................... 228
Chapter 23: antidepressants and mood stabilizers .............................................................................. 237
Unit vii: pain and inflammation management drugs .............................................................................. 248
Chapter 24: antiinflammatories ............................................................................................................ 248
, Chapter 25: analgesics .......................................................................................................................... 257
Unit viii: antimicrobial drugs.................................................................................................................... 266
Chapter 26. Penicillins, other beta-lactams, and cephalosporins ........................................................ 266
Chapter 27: macrolides, oxazolidinones, lincosamides, glycopeptides, ketolides, and lipopeptides .. 277
Chapter 28: tetracyclines, glycylcyclines, aminoglycosides, and fluoroquinolones ............................. 287
Chapter 29. Sulfonamides and nitroimidazoles antibiotics .................................................................. 292
Chapter 30. Antituberculars, antifungals, and antivirals ...................................................................... 299
Chapter 31. Antimalarials, anthelmintics, and peptides....................................................................... 311
Unit ix: immunologic drugs ...................................................................................................................... 314
Chapter 32. Hiv- and aids-related drugs ............................................................................................... 315
Chapter 33: transplant drugs ................................................................................................................ 323
Chapter 34: vaccines ............................................................................................................................. 326
Unit x: antineoplastics and biologic response modifiers ........................................................................ 332
Chapter 35: anticancer drugs ................................................................................................................ 332
Chapter 36: targeted therapies to treat cancer .................................................................................... 338
Chapter 37: biologic response modifiers .............................................................................................. 342
Unit xi: respiratory drugs ......................................................................................................................... 348
Chapter 38: upper respiratory disorders .............................................................................................. 348
Chapter 39: lower respiratory disorders............................................................................................... 354
Unit xii: cardiovascular drugs ................................................................................................................... 362
Chapter 40: cardiac glycosides, antianginals, and antidysrhythmics.................................................... 362
Chapter 41: diuretics............................................................................................................................. 372
Chapter 42: antihypertensives .............................................................................................................. 378
Chapter 43: anticoagulants, antiplatelets, and thrombolytics ............................................................. 386
Chapter 44: antihyperlipidemics and drugs to improve peripheral blood flow .................................. 395
Unit xiii: gastrointestinal drugs ................................................................................................................ 402
Chapter 45: gastrointestinal tract disorders ......................................................................................... 402
chapter 46: antiulcer drugs ................................................................................................................... 410
Unit xiv: eye, ear, and skin drugs ............................................................................................................. 418
Chapter 47: eye and ear disorders........................................................................................................ 418
Chapter 48: dermatologic disorders ..................................................................................................... 423
Unit xv: endocrine drugs .......................................................................................................................... 430
Chapter 49: pituitary, thyroid, parathyroid, and adrenal disorders ..................................................... 430
, Chapter 50: antidiabetics ...................................................................................................................... 440
Unit xvi: renal and urologic drugs ............................................................................................................ 449
Chapter 51: urinary disorders ............................................................................................................... 449
Unit xvii: reproductive and gender-related drugs................................................................................... 456
Chapter 52: pregnancy and preterm labor ........................................................................................... 456
Chapter 53: labor, delivery, and postpartum ....................................................................................... 465
chapter 54: neonatal and newborn ...................................................................................................... 471
Chapter 55: women’s reproductive health ........................................................................................... 474
Chapter 56: men’s reproductive health ................................................................................................ 483
Chapter 57: sexually transmitted infections ......................................................................................... 488
Unit xviii: emergency drugs ..................................................................................................................... 492
Chapter 58: adult and pediatric emergency drugs ............................................................................... 492
Unit i: introduction to pharmacology
Chapter 01: clinical judgment management model (cjmm) and the nursing process
Explanation of terms
McCuistion: pharmacology: a patient-centered nursing process approach, 12TH
edition
Multiple choice
1. Which characteristics are reflective of critical thinkers? Select all that apply.
A) aware of their personal biases
B) open-minded
C) impulsive
D) listen well
E) emotionally reactive
ANSWER:
A) aware of their personal biases
B) open-minded
D) listen well
, 2. According to paul and elder, clinical thinking requires which components? Select all that apply.
A) emotion
B) thought process
C) reasoning
D) intellectual standards
E) intellectual traits
ANSWER:
B) thought process
C) reasoning
D) intellectual standards
E) intellectual traits
3. Match the intellectual standard associated with the paul and elder framework with the
descriptive question.
Descriptive question:
- do i have a bias that needs to be addressed?
- does the answer make sense?
- can the thought be proven correct?
- are more details necessary?
Intellectual standard:
- depth
- fairness
- logic
, - significance
ANSWER:
Do i have a bias that needs to be addressed? Depth
Does the answer make sense? Significance
Can the thought be proven correct? Fairness
Are more details necessary? Logic
4. Which description best corresponds to the term clinical judgment?
A) used when discussing management scenarios or the reasoning process with nursing leadership
B) requires recalling facts and recognizing patterns seen previously when caring for patients
C) specific thought process used in nursing when analyzing, evaluating, and managing a patient
D) similar to clinical reasoning but considered a broader term in nursing
ANSWER: b) requires recalling facts and recognizing patterns seen previously when caring for patients
5. According to alfaro-lefevre, which factors can affect a nurse's ability to think critically? Select all
that apply.
A) life experience
B) self-confidence
C) gender
D) nursing role
E) moral development
ANSWER:
Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition by
Linda E. McCuistion, Kathleen Vuljoin DiMaggio, Mary B. Winton, Jennifer J. Yeager
12TH EDITION
, TABLE OF CONTENTS
Unit i: introduction to pharmacology ...................................................................................................... 4
Chapter 01: clinical judgment management model (cjmm) and the nursing process Explanation of
terms ......................................................................................................................................................... 4
Chapter 02: drug development and ethical considerations ................................................................... 27
Chapter 03: pharmacokinetics and pharmacodynamics ........................................................................ 38
Chapter 04: pharmacogenetics ............................................................................................................... 58
Chapter 05: complementary and alternative therapies ......................................................................... 63
Chapter 06: pediatric considerations...................................................................................................... 70
Chapter 07: drug therapy in older adults................................................................................................ 79
Chapter 08: drugs in substance use disorder ......................................................................................... 98
Unit ii: pharmacotherapy and drug administration ................................................................................ 105
Chapter 09: safety and quality .............................................................................................................. 105
Chapter 10: drug administration .......................................................................................................... 114
Chapter 11: drug labels and dosage calculations ................................................................................. 121
Unit iii: maintenance of homeostasis ...................................................................................................... 136
Chapter 12: fluid volume and electrolytes ........................................................................................... 136
Chapter 13: vitamin and mineral replacement ..................................................................................... 148
Chapter 14: nutritional support ............................................................................................................ 158
Unit iv: autonomic nervous system drugs ............................................................................................... 169
Chapter 15: adrenergic agonists and antagonists ................................................................................ 169
Chapter 16: cholinergic agonists and antagonists ................................................................................ 177
Unit v: central and peripheral nervous system drugs ............................................................................. 186
Chapter 17: stimulants .......................................................................................................................... 186
Chapter 18: depressants ....................................................................................................................... 192
Chapter 19: antiseizure drugs ............................................................................................................... 200
Chapter 20: drugs for parkinson disease and alzheimer disease ......................................................... 210
Chapter 21: drugs for neuromuscular disorders and muscle spasms................................................... 219
Unit vi: mental and behavioral health drugs........................................................................................... 228
Chapter 22: antipsychotics and anxiolytics........................................................................................... 228
Chapter 23: antidepressants and mood stabilizers .............................................................................. 237
Unit vii: pain and inflammation management drugs .............................................................................. 248
Chapter 24: antiinflammatories ............................................................................................................ 248
, Chapter 25: analgesics .......................................................................................................................... 257
Unit viii: antimicrobial drugs.................................................................................................................... 266
Chapter 26. Penicillins, other beta-lactams, and cephalosporins ........................................................ 266
Chapter 27: macrolides, oxazolidinones, lincosamides, glycopeptides, ketolides, and lipopeptides .. 277
Chapter 28: tetracyclines, glycylcyclines, aminoglycosides, and fluoroquinolones ............................. 287
Chapter 29. Sulfonamides and nitroimidazoles antibiotics .................................................................. 292
Chapter 30. Antituberculars, antifungals, and antivirals ...................................................................... 299
Chapter 31. Antimalarials, anthelmintics, and peptides....................................................................... 311
Unit ix: immunologic drugs ...................................................................................................................... 314
Chapter 32. Hiv- and aids-related drugs ............................................................................................... 315
Chapter 33: transplant drugs ................................................................................................................ 323
Chapter 34: vaccines ............................................................................................................................. 326
Unit x: antineoplastics and biologic response modifiers ........................................................................ 332
Chapter 35: anticancer drugs ................................................................................................................ 332
Chapter 36: targeted therapies to treat cancer .................................................................................... 338
Chapter 37: biologic response modifiers .............................................................................................. 342
Unit xi: respiratory drugs ......................................................................................................................... 348
Chapter 38: upper respiratory disorders .............................................................................................. 348
Chapter 39: lower respiratory disorders............................................................................................... 354
Unit xii: cardiovascular drugs ................................................................................................................... 362
Chapter 40: cardiac glycosides, antianginals, and antidysrhythmics.................................................... 362
Chapter 41: diuretics............................................................................................................................. 372
Chapter 42: antihypertensives .............................................................................................................. 378
Chapter 43: anticoagulants, antiplatelets, and thrombolytics ............................................................. 386
Chapter 44: antihyperlipidemics and drugs to improve peripheral blood flow .................................. 395
Unit xiii: gastrointestinal drugs ................................................................................................................ 402
Chapter 45: gastrointestinal tract disorders ......................................................................................... 402
chapter 46: antiulcer drugs ................................................................................................................... 410
Unit xiv: eye, ear, and skin drugs ............................................................................................................. 418
Chapter 47: eye and ear disorders........................................................................................................ 418
Chapter 48: dermatologic disorders ..................................................................................................... 423
Unit xv: endocrine drugs .......................................................................................................................... 430
Chapter 49: pituitary, thyroid, parathyroid, and adrenal disorders ..................................................... 430
, Chapter 50: antidiabetics ...................................................................................................................... 440
Unit xvi: renal and urologic drugs ............................................................................................................ 449
Chapter 51: urinary disorders ............................................................................................................... 449
Unit xvii: reproductive and gender-related drugs................................................................................... 456
Chapter 52: pregnancy and preterm labor ........................................................................................... 456
Chapter 53: labor, delivery, and postpartum ....................................................................................... 465
chapter 54: neonatal and newborn ...................................................................................................... 471
Chapter 55: women’s reproductive health ........................................................................................... 474
Chapter 56: men’s reproductive health ................................................................................................ 483
Chapter 57: sexually transmitted infections ......................................................................................... 488
Unit xviii: emergency drugs ..................................................................................................................... 492
Chapter 58: adult and pediatric emergency drugs ............................................................................... 492
Unit i: introduction to pharmacology
Chapter 01: clinical judgment management model (cjmm) and the nursing process
Explanation of terms
McCuistion: pharmacology: a patient-centered nursing process approach, 12TH
edition
Multiple choice
1. Which characteristics are reflective of critical thinkers? Select all that apply.
A) aware of their personal biases
B) open-minded
C) impulsive
D) listen well
E) emotionally reactive
ANSWER:
A) aware of their personal biases
B) open-minded
D) listen well
, 2. According to paul and elder, clinical thinking requires which components? Select all that apply.
A) emotion
B) thought process
C) reasoning
D) intellectual standards
E) intellectual traits
ANSWER:
B) thought process
C) reasoning
D) intellectual standards
E) intellectual traits
3. Match the intellectual standard associated with the paul and elder framework with the
descriptive question.
Descriptive question:
- do i have a bias that needs to be addressed?
- does the answer make sense?
- can the thought be proven correct?
- are more details necessary?
Intellectual standard:
- depth
- fairness
- logic
, - significance
ANSWER:
Do i have a bias that needs to be addressed? Depth
Does the answer make sense? Significance
Can the thought be proven correct? Fairness
Are more details necessary? Logic
4. Which description best corresponds to the term clinical judgment?
A) used when discussing management scenarios or the reasoning process with nursing leadership
B) requires recalling facts and recognizing patterns seen previously when caring for patients
C) specific thought process used in nursing when analyzing, evaluating, and managing a patient
D) similar to clinical reasoning but considered a broader term in nursing
ANSWER: b) requires recalling facts and recognizing patterns seen previously when caring for patients
5. According to alfaro-lefevre, which factors can affect a nurse's ability to think critically? Select all
that apply.
A) life experience
B) self-confidence
C) gender
D) nursing role
E) moral development
ANSWER:
